Company Profile

Advanced Cytometry Instrumentation Systems
Profile last edited on: 12/21/2017      CAGE: 3A1W0      UEI: YLGMJXLP7TW5

Business Identifier: Flow cytometry (cell analysis)
Year Founded
2001
First Award
2001
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

Baird Research Park 1576 Sweet Home Road
Amherst, NY 14228
   (716) 689-9797
   information@acisflowcyte.com
   www.acisflowcyte.com
Location: Single
Congr. District: 26
County: Erie

Public Profile

Advanced Cytometry Instrumentation Systems (ACIS) works in flow cytometry - an extremely versatile technique used for biotechnology applications. The technique analyzes the specific molecular composition of cells (one cell at a time) and can be used clinically, in the research laboratory and beyond. ACIS was formed from the collaboration of three parties: two renown researchers in flow cytometry and biophotonics and a company with expertise in lasers and optics. This well-balanced team is poised to take advantage of the most recent developments in components and developed (over several years) proprietary and patent-pending innovations in flow cytometry instrumentation to increase performance and to reduce the size and costs. ACIS is committed to delivering high performance flow cytometers and related products to its customers that are expandable, upgradable, and cost effective.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Nicole Kuzmin-Nichols -- President & COO

  Dalar Bansal

  Martin Casstevens

  Andrey Kuzmin

Company News

There are no news available.